Cargando…
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
BACKGROUND: In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcripti...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234580/ https://www.ncbi.nlm.nih.gov/pubmed/30424786 http://dx.doi.org/10.1186/s13395-018-0179-5 |
_version_ | 1783370723058778112 |
---|---|
author | Billin, Andrew N. Honeycutt, Samuel E. McDougal, Alan V. Kerr, Jaclyn P. Chen, Zhe Freudenberg, Johannes M. Rajpal, Deepak K. Luo, Guizhen Kramer, Henning Fritz Geske, Robert S. Fang, Frank Yao, Bert Clark, Richard V. Lepore, John Cobitz, Alex Miller, Ram Nosaka, Kazunori Hinken, Aaron C. Russell, Alan J. |
author_facet | Billin, Andrew N. Honeycutt, Samuel E. McDougal, Alan V. Kerr, Jaclyn P. Chen, Zhe Freudenberg, Johannes M. Rajpal, Deepak K. Luo, Guizhen Kramer, Henning Fritz Geske, Robert S. Fang, Frank Yao, Bert Clark, Richard V. Lepore, John Cobitz, Alex Miller, Ram Nosaka, Kazunori Hinken, Aaron C. Russell, Alan J. |
author_sort | Billin, Andrew N. |
collection | PubMed |
description | BACKGROUND: In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcription under conditions of low oxygen, and HIF target genes EPO and VEGF have been associated with muscle protection and repair. We tested the importance of HIF activation following skeletal muscle injury, in both a murine model and human volunteers, using prolyl hydroxylase inhibitors that stabilize and activate HIF. METHODS: Using a mouse eccentric limb injury model, we characterized the protective effects of prolyl hydroxylase inhibitor, GSK1120360A. We then extended these studies to examine the impact of EPO modulation and infiltrating immune cell populations on muscle protection. Finally, we extended this study with an experimental medicine approach using eccentric arm exercise in untrained volunteers to measure the muscle-protective effects of a clinical prolyl hydroxylase inhibitor, daprodustat. RESULTS: GSK1120360A dramatically prevented functional deficits and histological damage, while accelerating recovery after eccentric limb injury in mice. Surprisingly, this effect was independent of EPO, but required myeloid HIF1α-mediated iNOS activity. Treatment of healthy human volunteers with high-dose daprodustat reduced accumulation of circulating damage markers following eccentric arm exercise, although we did not observe any diminution of functional deficits with compound treatment. CONCLUSION: The results of these experiments highlight a novel skeletal muscle protective effect of prolyl hydroxylase inhibition via HIF-mediated expression of iNOS in macrophages. Partial recapitulation of these findings in healthy volunteers suggests elements of consistent pharmacology compared to responses in mice although there are clear differences between these two systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13395-018-0179-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6234580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62345802018-11-23 HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury Billin, Andrew N. Honeycutt, Samuel E. McDougal, Alan V. Kerr, Jaclyn P. Chen, Zhe Freudenberg, Johannes M. Rajpal, Deepak K. Luo, Guizhen Kramer, Henning Fritz Geske, Robert S. Fang, Frank Yao, Bert Clark, Richard V. Lepore, John Cobitz, Alex Miller, Ram Nosaka, Kazunori Hinken, Aaron C. Russell, Alan J. Skelet Muscle Research BACKGROUND: In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcription under conditions of low oxygen, and HIF target genes EPO and VEGF have been associated with muscle protection and repair. We tested the importance of HIF activation following skeletal muscle injury, in both a murine model and human volunteers, using prolyl hydroxylase inhibitors that stabilize and activate HIF. METHODS: Using a mouse eccentric limb injury model, we characterized the protective effects of prolyl hydroxylase inhibitor, GSK1120360A. We then extended these studies to examine the impact of EPO modulation and infiltrating immune cell populations on muscle protection. Finally, we extended this study with an experimental medicine approach using eccentric arm exercise in untrained volunteers to measure the muscle-protective effects of a clinical prolyl hydroxylase inhibitor, daprodustat. RESULTS: GSK1120360A dramatically prevented functional deficits and histological damage, while accelerating recovery after eccentric limb injury in mice. Surprisingly, this effect was independent of EPO, but required myeloid HIF1α-mediated iNOS activity. Treatment of healthy human volunteers with high-dose daprodustat reduced accumulation of circulating damage markers following eccentric arm exercise, although we did not observe any diminution of functional deficits with compound treatment. CONCLUSION: The results of these experiments highlight a novel skeletal muscle protective effect of prolyl hydroxylase inhibition via HIF-mediated expression of iNOS in macrophages. Partial recapitulation of these findings in healthy volunteers suggests elements of consistent pharmacology compared to responses in mice although there are clear differences between these two systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13395-018-0179-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-13 /pmc/articles/PMC6234580/ /pubmed/30424786 http://dx.doi.org/10.1186/s13395-018-0179-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Billin, Andrew N. Honeycutt, Samuel E. McDougal, Alan V. Kerr, Jaclyn P. Chen, Zhe Freudenberg, Johannes M. Rajpal, Deepak K. Luo, Guizhen Kramer, Henning Fritz Geske, Robert S. Fang, Frank Yao, Bert Clark, Richard V. Lepore, John Cobitz, Alex Miller, Ram Nosaka, Kazunori Hinken, Aaron C. Russell, Alan J. HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
title | HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
title_full | HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
title_fullStr | HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
title_full_unstemmed | HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
title_short | HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
title_sort | hif prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234580/ https://www.ncbi.nlm.nih.gov/pubmed/30424786 http://dx.doi.org/10.1186/s13395-018-0179-5 |
work_keys_str_mv | AT billinandrewn hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT honeycuttsamuele hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT mcdougalalanv hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT kerrjaclynp hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT chenzhe hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT freudenbergjohannesm hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT rajpaldeepakk hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT luoguizhen hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT kramerhenningfritz hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT geskeroberts hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT fangfrank hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT yaobert hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT clarkrichardv hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT leporejohn hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT cobitzalex hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT millerram hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT nosakakazunori hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT hinkenaaronc hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury AT russellalanj hifprolylhydroxylaseinhibitionprotectsskeletalmusclefromeccentriccontractioninducedinjury |